PGEN (Precigen) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PGEN Precigen Inc PGEN
53 GF Score
Price $7.75
GF Value $14.89
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Precigen Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Precigen  (NAS:PGEN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Precigen Cyclically Adjusted PS Ratio Related Terms


Precigen Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Precigen's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precigen Cyclically Adjusted PS Ratio Chart

Precigen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.61 1.39 1.27 1.14 5.21

Precigen Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 3.74 5.03 4.83 7.48

PGEN vs PHVS, NKTR, VERA: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Precigen's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precigen Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Precigen's Cyclically Adjusted PS Ratio falls into.


PGEN
53GF Score
Precigen Inc PGEN
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precigen Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Precigen's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Precigen's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.133/333.9520*333.9520
=0.133

Current CPI (Jun. 2026) = 333.9520.

Precigen Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.414 241.428 0.573
201612 0.388 241.432 0.537
201703 0.452 243.801 0.619
201706 0.455 244.955 0.620
201709 0.382 246.819 0.517
201712 0.638 246.524 0.864
201803 0.343 249.554 0.459
201806 0.350 251.989 0.464
201809 0.251 252.439 0.332
201812 0.313 251.233 0.416
201903 0.148 254.202 0.194
201906 0.214 256.143 0.279
201909 0.118 256.759 0.153
201912 0.110 256.974 0.143
202003 0.186 258.115 0.241
202006 0.185 257.797 0.240
202009 0.142 260.280 0.182
202012 0.108 260.474 0.138
202103 0.127 264.877 0.160
202106 0.019 271.696 0.023
202109 0.017 274.310 0.021
202112 0.018 278.802 0.022
202203 0.028 287.504 0.033
202206 0.015 296.311 0.017
202209 0.083 296.808 0.093
202212 0.008 296.797 0.009
202303 0.008 301.836 0.009
202306 0.007 305.109 0.008
202309 0.006 307.789 0.007
202312 0.005 306.746 0.005
202403 0.004 312.332 0.004
202406 0.003 314.175 0.003
202409 0.003 315.301 0.003
202412 0.004 315.605 0.004
202503 0.005 319.799 0.005
202506 0.003 322.561 0.003
202509 0.010 324.800 0.010
202512 0.013 324.054 0.013
202603 0.066 330.213 0.067
202606 0.133 333.952 0.133

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Precigen (PGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Precigen stock appears to be undervalued. The current stock price of $7.75 is trading 48% below its estimated GF Value™ of $14.89. GuruFocus considers Precigen to be Possible Value Trap.

Key valuation signals for PGEN:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $14.89 vs. price of $7.75 (48% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the PGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Precigen Business Description

Other Exchanges I5X:Germany
Address 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
53GF Score

Get the complete analysis for PGEN

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.75
Price
$14.89
GF Value